In this work, we developed an integrated, portable electrochemiluminescence (ECL)-based device for rapid and quantitative detection of tumor necrosis factor alpha (TNF-α), a pivotal inflammatory marker in ocular surface disease, with particular relevance to dry eye syndrome (DES). Here, TNF is linked to dry eye syndrome.